Author/Authors :
Ghanaati, Hossein tehran university of medical sciences tums - Faculty of Medicine, Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Imam Khomeini Hospital - Department of Radiology, تهران, ايران , Alavian, Moayed baqiyatallah university of medical sciences - Baqiyatallah Research Center for Gastroenterology and Liver Diseases, ايران , Jafarian, Ali tehran university of medical sciences tums - Faculty of Medicine - Hepatobilliary and Liver Transplantation Division, تهران, ايران , Ebrahimi Daryani, Nasser tehran university of medical sciences tums - Faculty of Medicine - Department of Gastroenterology, تهران, ايران , Nassiri-Toosi, Mohsen tehran university of medical sciences tums - Faculty of Medicine - Department of Gastroenterology, تهران, ايران , Jalali, Amir Hossein tehran university of medical sciences tums - Advanced Diagnostic and Interventional Radiology Research Center (ADIR), تهران, ايران , Shakiba, Madjid tehran university of medical sciences tums - Advanced Diagnostic and Interventional Radiology Research Center (ADIR), تهران, ايران
Abstract :
The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.
Keywords :
Carcinoma, Hepatocellular , Radiology, Interventional , Chemoembolization, herapeutic , Iran , Risk Factors
